This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/domain/vavai/projekt/
n15http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n14http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F67985823%3A_____%2F98%3A20980119%21RIV%2F2001%2FAV0%2FA20001%2FN/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n13http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F67985823%3A_____%2F98%3A20980119%21RIV%2F2001%2FAV0%2FA20001%2FN
rdf:type
skos:Concept n15:Vysledek
dcterms:description
Annotation not available Annotation not available
dcterms:title
Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage. Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage.
skos:prefLabel
Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage. Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage.
skos:notation
RIV/67985823:_____/98:20980119!RIV/2001/AV0/A20001/N
n3:strany
697
n3:aktivita
n7:P
n3:aktivity
P(GV306/96/K220)
n3:cisloPeriodika
9-10
n3:dodaniDat
n13:2001
n3:domaciTvurceVysledku
Dobiášová, Milada Rauchová, Hana
n3:druhVysledku
n9:J
n3:duvernostUdaju
n11:S
n3:entitaPredkladatele
n14:predkladatel
n3:idSjednocenehoVysledku
763494
n3:idVysledku
RIV/67985823:_____/98:20980119
n3:jazykVysledku
n4:eng
n3:kodStatuVydavatele
DE - Spolková republika Německo
n3:kontrolniKodProRIV
[E0674367A83D]
n3:nazevZdroje
European Journal of Clinical Pharmacology
n3:obor
n12:FR
n3:pocetDomacichTvurcuVysledku
2
n3:pocetTvurcuVysledku
6
n3:projekt
n5:GV306%2F96%2FK220
n3:rokUplatneniVysledku
n13:1998
n3:svazekPeriodika
54
n3:tvurceVysledku
Dobiášová, Milada Fábry, R. Dušinská, M. Rašlová, K. Rauchová, Hana Nagyová, A.
s:issn
0031-6970
s:numberOfPages
3